-
Appaiahgari M B, Vrati S, 2010: IMOJEV (R): a Yellow fever virus-based novel Japanese encephalitis vaccine[J]. Expert Review of Vaccines, 9, 1371-1384. doi: 10.1586/erv.10.139
-
Calisher C H, Karabatsos N, Dalrymple J M, Shope R E, Porterfield J S, Westaway E G, Brandt W E, 1989: Antigenic Relationships between Flaviviruses as Determined by Cross-Neutralization Tests with Polyclonal Antisera[J]. Journal of General Virology, 70, 37-43. doi: 10.1099/0022-1317-70-1-37
-
Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, 2011: Estimated global incidence of Japanese encephalitis: a systematic review[J]. Bull World Health Organ, 89, 766-774E. doi: 10.2471/BLT.00.000000
-
Chavez J H, Silva J R, Amarilla A A, Moraes Figueiredo L T, 2010: Domain Ⅲ peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization[J]. Biologicals, 38, 613-618. doi: 10.1016/j.biologicals.2010.07.004
-
Chien Y J, Chen W J, Hsu W L, Chiou S S, 2008: Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein[J]. Virology, 379, 143-151. doi: 10.1016/j.virol.2008.06.017
-
Chow L, Sun H C, Chen H Y, Lin S Y, Wu J S, 1992: Detection and differentiation of dengue-1 from Japanese encephalitis virus infections by ABC MAC-ELISA[J]. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, 25, 172-180.
-
Chu J H, Chiang C C, Ng M L, 2007: Immunization of flavivirus West Nile recombinant envelope domain Ⅲ protein induced specific immune response and protection against West Nile virus infection[J]. J Immunol, 178, 2699-2705. doi: 10.4049/jimmunol.178.5.2699
-
Chu J J H, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng M L, 2005: Inhibition of West Nile virus entry by using a recombinant domain Ⅲ from the envelope glycoprotein[J]. Journal of General Virology, 86, 405-412. doi: 10.1099/vir.0.80411-0
-
Crill W D, Roehrig J T, 2001: Monoclonal antibodies that bind to domain Ⅲ of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells[J]. Journal of Virology, 75, 7769-7773. doi: 10.1128/JVI.75.16.7769-7773.2001
-
Dou J L, Jing T, Fan JJ, Yuan ZM, 2011: Surface display of domain Ⅲ of Japanese encephalitis virus E protein on Salmonella typhimurium by using an ice nucleation protein[J]. Virol Sin, 26, 409-417. doi: 10.1007/s12250-011-3216-7
-
Eder S, Dubischar-Kastner K, Firbas C, Jelinek T, Jilma B, Kaltenboeck A, Knappik M, Kollaritsch H, Kundi M, Paulke-Korinek M, Schuller E, Klade C S, 2011: Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO (R), IC51[J]. Vaccine, 29, 2607-2612. doi: 10.1016/j.vaccine.2011.01.058
-
Ghosh D, Basu A, 2009: Japanese Encephalitis — A Pathological and Clinical Perspective[J]. Plos Neglected Tropical Diseases, 3, -.
-
Heinz F X, Stiasny K, Puschnerauer G, Holzmann H, Allison S L, Mandl C W, Kunz C, 1994: Structural-Changes and Functional Control of the Tick-Borne Encephalitis-Virus Glycoprotein-E by the Heterodimeric Association with Protein Prm[J]. Virology, 198, 109-117. doi: 10.1006/viro.1994.1013
-
Hennessy S, Liu Z L, Tsai T F, Strom B L, Wan C M, Liu H L, Wu T X, Yu H J, Liu Q M, Karabatsos N, Bilker W B, Halstead S B, 1996: Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): A case-control study[J]. Lancet, 347, 1583-1586. doi: 10.1016/S0140-6736(96)91075-2
-
Hoke C H, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis B L, Kotchasenee S O, Gingrich J B, Latendresse J, Fukai K, Burke D S, 1988: Protection against Japanese Encephalitis by Inactivated Vaccines[J]. New England Journal of Medicine, 319, 608-614. doi: 10.1056/NEJM198809083191004
-
Jones C T, Ma L, Burgner J W, Groesch T D, Post C B, Kuhn R J, 2003: Flavivirus capsid is a dimeric alpha-helical protein[J]. J Virol, 77, 7143-7149. doi: 10.1128/JVI.77.12.7143-7149.2003
-
Kanai R, Kar K, Anthony K, Gould L H, Ledizet M, Fikrig E, Marasco W A, Koski R A, Modis Y, 2006: Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes[J]. J Virol, 80, 11000-11008. doi: 10.1128/JVI.01735-06
-
Konno J, Endo K, Agatsuma H, Ishida N, 1966: Cyclic Outbreaks of Japanese Encephalitis among Pigs and Humans[J]. American Journal of Epidemiology, 84, 292-&. doi: 10.1093/oxfordjournals.aje.a120643
-
Kuhn R J, Zhang W, Rossmann M G, Pletnev S V, Corver J, Lenches E, Jones C T, Mukhopadhyay S, Chipman P R, Strauss E G, Baker T S, Strauss J H, 2002: Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion[J]. Cell, 108, 717-725. doi: 10.1016/S0092-8674(02)00660-8
-
Li S H, Li X F, Zhao H, Jiang T, Deng Y Q, Yu X D, Zhu Q Y, Qin E D, Qin C F, 2011: Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain Ⅲ of Japanese encephalitis virus[J]. Immunol Lett, 138, 156-160. doi: 10.1016/j.imlet.2011.04.003
-
Lindenbach B D, H. J. Thiel, and C. M. Rice. 2007. Flaviviridae: the virus and their replication. In Howley D M K a P M (ed. ), Fields virology, 5th ed, vol. 1, Lippincott-Raven, Philadelphia, Pa.
-
Lozach P Y, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier J L, Rey F A, Despres P, Arenzana-Seisdedos F, Amara A, 2005: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals[J]. J Biol Chem, 280, 23698-23708. doi: 10.1074/jbc.M504337200
-
Luca V C, AbiMansour J, Nelson C A, Fremont D H, 2012: Crystal structure of the Japanese encephalitis virus envelope protein[J]. J Virol, 86, 2337-2346. doi: 10.1128/JVI.06072-11
-
Miller J L, de Wet B J, Martinez-Pomares L, Radcliffe C M, Dwek R A, Rudd P M, Gordon S, 2008: The mannose receptor mediates dengue virus infection of macrophages[J]. PLoS Pathog, 4, e17-. doi: 10.1371/journal.ppat.0040017
-
Modis Y, Ogata S, Clements D, Harrison S C, 2003: A ligand-binding pocket in the dengue virus envelope glycoprotein[J]. Proc Natl Acad Sci U S A, 100, 6986-6991. doi: 10.1073/pnas.0832193100
-
Nothdurft H D, Jelinek T, Marschang A, Maiwald H, Kapaun A, Loscher T, 1996: Adverse reactions to Japanese encephalitis vaccine in travellers[J]. J Infect, 32, 119-122. doi: 10.1016/S0163-4453(96)91281-5
-
Nybakken G E, Oliphant T, Johnson S, Burke S, Diamond M S, Fremont D H, 2005: Structural basis of West Nile virus neutralization by a therapeutic antibody[J]. Nature, 437, 764-769. doi: 10.1038/nature03956
-
Plesner A M, Arlien-Soborg P., Herning M., 1998: Neurological complications to vaccination against Japanese encephalitis[J]. the official journal of the European Federation of Neurological Societies, 5, 479-485. doi: 10.1046/j.1468-1331.1998.550479.x
-
Rajamanonmani R, Nkenfou C, Clancy P, Yau Y H, Shochat S G, Sukupolvi-Petty S, Schul W, Diamond M S, Vasudevan S G, Lescar J, 2009: On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes[J]. Journal of General Virology, 90, 799-809. doi: 10.1099/vir.0.006874-0
-
Rey F A, Heinz F X, Mandl C, Kunz C, Harrison S C, 1995: The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution[J]. Nature, 375, 291-298. doi: 10.1038/375291a0
-
Schioler K L, Samuel M, and Wai K L. 2007. Vaccines for preventing Japanese encephalitis. Cochrane Database Syst Rev: CD004263.
-
Song B H, Yun G N, Kim J K, Yun S I, Lee Y M, 2012: Biological and genetic properties of SA(14)-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans[J]. Journal of Microbiology, 50, 698-706. doi: 10.1007/s12275-012-2336-6
-
Tesh R B, da Rosa A P A T, Guzman H, Araujo T P, Xiao S Y, 2002: Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis[J]. Emerging Infectious Diseases, 8, 245-251. doi: 10.3201/eid0803.010238
-
Wu K P, Wu C W, Tsao Y P, Kuo T W, Lou Y C, Lin C W, Wu S C, Cheng J W, 2003: Structural basis of a flavivirus recognized by its neutralizing antibody — Solution structure of the domain Ⅲ of the Japanese encephalitis virus envelope protein[J]. Journal of Biological Chemistry, 278, 46007-46013. doi: 10.1074/jbc.M307776200
-
Yu I M, Zhang W, Holdaway H A, Li L, Kostyuchenko V A, Chipman P R, Kuhn R J, Rossmann M G, Chen J, 2008: Structure of the immature dengue virus at low pH primes proteolytic maturation[J]. Science, 319, 1834-1837. doi: 10.1126/science.1153264
-
Zaitseva E, Yang S T, Melikov K, Pourmal S, and Chernomordik L V. 2010. Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids. PLoS Pathog, 6.